Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 26371143

Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2016 Mar 10
First author
Demetri GD

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2016 Mar 10;34(8):769-71. doi: 10.1200/JCO.2015.63.5938.
    note
    Source null
    related pmid
    26371135
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2016 Oct 10;34(29):3583. doi: 10.1200/JCO.2016.68.3029.
    note
    Source null
    related pmid
    27458282
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2016 Oct 10;34(29):3582-3583. doi: 10.1200/JCO.2015.65.7130.
    note
    Source null
    related pmid
    27458287
    relationship
    Comment in
  4. citation
    J Clin Oncol. 2016 Oct 10;34(29):3584. doi: 10.1200/JCO.2016.68.3037.
    note
    Source null
    related pmid
    27458303
    relationship
    Comment in

Authors and identifiers

  1. name
    Demetri GD
    type
    Author
  2. name
    von Mehren M
    type
    Author
  3. name
    Jones RL
    type
    Author
  4. name
    Hensley ML
    type
    Author
  5. name
    Schuetze SM
    type
    Author
  6. name
    Staddon A
    type
    Author
  7. name
    Milhem M
    type
    Author
  8. name
    Elias A
    type
    Author
  9. name
    Ganjoo K
    type
    Author
  10. name
    Tawbi H
    type
    Author
  11. name
    Van Tine BA
    type
    Author
  12. name
    Spira A
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Demetri GD
    type
    Author
  2. name
    von Mehren M
    type
    Author
  3. name
    Jones RL
    type
    Author
  4. name
    Hensley ML
    type
    Author
  5. name
    Schuetze SM
    type
    Author
  6. name
    Staddon A
    type
    Author
  7. name
    Milhem M
    type
    Author
  8. name
    Elias A
    type
    Author
  9. name
    Ganjoo K
    type
    Author
  10. name
    Tawbi H
    type
    Author
  11. name
    Van Tine BA
    type
    Author
  12. name
    Spira A
    type
    Author
bibliography ids
  1. nci-bib-31261e92cc3e5e73f9da85d8
book metadata
content sha256
4d57b6a84ca6526a9f9e57d382b000a75a8b22c057f7237d73a33d26792b4541
document type
citation
dois
  1. 10.1200/JCO.2015.62.4734
electronic publication date
display
2015 Sep 14
precision
day
year
2015
evidence scope
bibliographic_metadata_only
id
pubmed:26371143
immutable id
pubmed:26371143@4d57b6a84ca6526a9f9e57d382b000a75a8b22c057f7237d73a33d26792b4541
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
8
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
786-93
volume
34
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2016 Mar 10;34(8):769-71. doi: 10.1200/JCO.2015.63.5938.
    note
    Source null
    related pmid
    26371135
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2016 Oct 10;34(29):3583. doi: 10.1200/JCO.2016.68.3029.
    note
    Source null
    related pmid
    27458282
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2016 Oct 10;34(29):3582-3583. doi: 10.1200/JCO.2015.65.7130.
    note
    Source null
    related pmid
    27458287
    relationship
    Comment in
  4. citation
    J Clin Oncol. 2016 Oct 10;34(29):3584. doi: 10.1200/JCO.2016.68.3037.
    note
    Source null
    related pmid
    27458303
    relationship
    Comment in
outcomes validated
false
pmid
26371143
provenance
batch id
4c1ece5bfc3d8e2be622
provider
NCBI PubMed ESummary
record sha256
8f8f5a94883b74feebfd3a48acb98f218658d46a185eee3630383bf147a83fff
response sha256
85f81bf7b60c457e4b5806b47c7c67c745ada2ae114069aa45de5ef977770dba
retrieved at
2026-09-09T23:47:12.730551+00:00
publication date
display
2016 Mar 10
precision
day
year
2016
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/26371143/
title
Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial.

Preserved source evidence · Not medical advice